Lower-urinary-tract symptoms in men. Free to use.
IPSS (International Prostate Symptom Score) is a validated clinical instrument used to assess lower-urinary-tract symptoms in men. The instrument contains 7 items.
Source / attribution: Barry MJ et al. J Urol. 1992;148(5):1549-1557.
The instrument's primary construct — lower-urinary-tract symptoms in men — is operationalized through a fixed set of items, each with a defined response format. This standardisation is what allows IPSS scores to be compared meaningfully across clinicians, sites, and studies.
Like all screening or assessment instruments, IPSS is a structured aid — not a diagnostic test in isolation. Results should be interpreted alongside history, examination, and clinical context. Where a score crosses an actionable threshold, the next step is typically a more detailed clinical evaluation rather than a definitive diagnosis.
Answer all 7 items below to see your IPSS score and interpretation.
Each item is scored on a 6-point scale (0–5). Your score updates live as you answer.
All scoring runs in your browser. No data is sent anywhere — close the tab and the answers are gone.
IPSS uses simple summation: each item's selected response is converted to a numeric value, and the values are added to produce a total score. Reverse-scored items are inverted before summation.
Scoring notes: An additional Quality of Life question (0–6) is recommended but is not summed into the IPSS total.
The cutoffs below are drawn from the published validation literature. Always interpret in clinical context.
| Score range | Band | Interpretation |
|---|---|---|
| 0–7 | Mildly symptomatic | Watchful waiting or lifestyle measures. |
| 8–19 | Moderately symptomatic | Medical therapy commonly indicated. |
| 20–35 | Severely symptomatic | Consider urological referral; surgery may be appropriate. |
This is an illustrative walkthrough, not a real patient. Follow the same four steps with your own answers — or use the live calculator at the top of this page.
Read each question and choose the response that best fits. Each response has a number next to it — that number is the item's score. The example below uses illustrative answers.
| # | Item | Example response | Score |
|---|---|---|---|
| 1 | Incomplete emptying | < 1 in 5 | 1 |
| 2 | Frequency (< 2 h between voids) | Not at all | 0 |
| 3 | Intermittency (stop / start) | < 1 in 5 | 1 |
| 4 | Urgency (difficult to postpone) | Not at all | 0 |
| 5 | Weak stream | < 1 in 5 | 1 |
| 6 | Straining | Not at all | 0 |
| 7 | Nocturia (number of times) | 1 | 1 |
Add up all the item scores you noted in Step 1.
1 + 0 + 1 + 0 + 1 + 0 + 1 = 4
Find the row in the interpretation table whose range contains your total:
Total = 4 falls between 0 and 7 → Mildly symptomatic
Mildly symptomatic. Watchful waiting or lifestyle measures.
A score is one input alongside history and examination. IPSS supports clinical judgment — it does not replace it.
If IPSS doesn't fit your context, related instruments in urology include:
| Scale | Measures | Items | Time |
|---|---|---|---|
| IIEF-5 / SHIM | Erectile dysfunction screen | 5 | — |
| ODI | Self-reported low-back-pain functional disability | 10 | — |
| NDI | Self-reported neck-pain functional disability | 10 | — |
| Oxford Knee Score | Pain and function after total knee replacement | 12 | — |
| Oxford Hip Score | Pain and function after total hip replacement | 12 | — |
| LEFS | Function with lower-extremity musculoskeletal disorders | 20 | — |
| DLQI | Skin-disease impact on health-related quality of life | 10 | ≈ 2 minutes |
| POEM | Atopic eczema severity over the past week | 7 | — |
IPSS (International Prostate Symptom Score) is a validated instrument that assesses lower-urinary-tract symptoms in men. It is designed for clinicians, medical students, evidence-synthesis researchers. The 7 items are summed to produce a total score.
IPSS contains 7 items. Item scores are summed to produce the total. Scores run from 0 to 35, grouped into 3 interpretation bands from ‘Mildly symptomatic’ up to ‘Severely symptomatic’.
On the IPSS (total score 0–35), scores of 20–35 fall in the ‘Severely symptomatic’ band — interpreted as: Consider urological referral; surgery may be appropriate. The full ladder is: 0–7 — Mildly symptomatic: Watchful waiting or lifestyle measures.; 8–19 — Moderately symptomatic: Medical therapy commonly indicated.; 20–35 — Severely symptomatic: Consider urological referral; surgery may be appropriate. A higher score reflects a more severe presentation, and crossing a cutoff is a prompt to step up assessment or care — but these bands are screening thresholds, not diagnoses.
Scores of 0–7 fall in the ‘Mildly symptomatic’ band: Watchful waiting or lifestyle measures. A low score is reassuring but does not by itself rule out the underlying condition — if symptoms or clinical suspicion persist, reassess over time or use a complementary evaluation rather than relying on the number alone.
Yes — IPSS is in the public domain and free for clinical, educational, and research use without permission. You can use this calculator and the scale itself freely; if you publish results or reproduce the scale, cite the original source paper.
Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549-1557. This is the original publication for the IPSS — the reference to cite when reporting results.
No. IPSS is a structured assessment aid, not a diagnostic test. Its proper role is clinical assessment of lower-urinary-tract symptoms in men — it standardizes assessment and flags who needs closer evaluation, but the result must be weighed alongside history, examination, and clinical context. When a score conflicts with your clinical impression, clinical judgment takes precedence; treatment decisions should never rest on a screening score alone.
IPSS is supported by the following peer-reviewed sources: